Phase 2
-
A Clinical Study of Arfolitixorin in Patients With mCRC
Phase 2 · randomised · 90 people · 3 sites in Germany · Recruiting now
-
Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
Phase 2 · randomised · 66 people · 1 site in United States · Recruiting now
-
Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
Phase 2 · 100 people · 11 sites in United States · Recruiting now
-
Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer（Neo-Color）
Phase 2 · randomised · 128 people · 1 site in China · Recruiting now
-
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Phase 2 · 140 people · 48 sites in 8 countries · Recruiting now
-
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
Phase 2 · randomised · 90 people · 17 sites in 2 countries · Recruiting now